ANI Pharmaceuticals ANIP Generics and Other — Other (expense)income , net
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by ANI Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.
The official record: ANI Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about ANI Pharmaceuticals's generics and other — other (expense)income , net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is ANI Pharmaceuticals's generics and other — other (expense)income , net?
- ANI Pharmaceuticals (ANIP) reported generics and other — other (expense)income , net of $0 in Q1 2026.
- What does generics and other — other (expense)income , net mean?
- Includes miscellaneous non-operating income or expenses that do not fit into standard categories like interest or taxes, such as foreign exchange gains or losses. It provides a view into peripheral financial events that impact the segment's overall net contribution.